178 related articles for article (PubMed ID: 31418468)
1. Radiosynthesis of the diastereomerically pure (E)-[
Bdair H; Tsai IH; Smart K; Benkelfat C; Leyton M; Kostikov A
J Labelled Comp Radiopharm; 2019 Oct; 62(12):860-864. PubMed ID: 31418468
[TBL] [Abstract][Full Text] [Related]
2. Binding potential of (E)-[¹¹C]ABP688 to metabotropic glutamate receptor subtype 5 is decreased by the inclusion of its ¹¹C-labelled Z-isomer.
Kawamura K; Yamasaki T; Kumata K; Furutsuka K; Takei M; Wakizaka H; Fujinaga M; Kariya K; Yui J; Hatori A; Xie L; Shimoda Y; Hashimoto H; Hayashi K; Zhang MR
Nucl Med Biol; 2014 Jan; 41(1):17-23. PubMed ID: 24183615
[TBL] [Abstract][Full Text] [Related]
3. Radiosynthesis and preclinical evaluation of 11C-ABP688 as a probe for imaging the metabotropic glutamate receptor subtype 5.
Ametamey SM; Kessler LJ; Honer M; Wyss MT; Buck A; Hintermann S; Auberson YP; Gasparini F; Schubiger PA
J Nucl Med; 2006 Apr; 47(4):698-705. PubMed ID: 16595505
[TBL] [Abstract][Full Text] [Related]
4. Automated cGMP-compliant radiosynthesis of [
Park JY; Son J; Yun M; Ametamey SM; Chun JH
J Labelled Comp Radiopharm; 2018 Jan; 61(1):30-37. PubMed ID: 28948638
[TBL] [Abstract][Full Text] [Related]
5. Automated GMP-production of α-[
Nordeman P; Yngve U; Wilking H; Gustavsson SÅ; Eriksson J; Antoni G
J Labelled Comp Radiopharm; 2018 Dec; 61(14):1106-1109. PubMed ID: 29902836
[TBL] [Abstract][Full Text] [Related]
6. Synthesis and evaluation of novel α-fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyl oxime (ABP688) derivatives as metabotropic glutamate receptor subtype 5 PET radiotracers.
Milicevic Sephton S; Mu L; Schweizer WB; Schibli R; Krämer SD; Ametamey SM
J Med Chem; 2012 Aug; 55(16):7154-62. PubMed ID: 22822714
[TBL] [Abstract][Full Text] [Related]
7. Structure-activity relationships of fluorinated (E)-3-((6-methylpyridin-2-yl)ethynyl)cyclohex-2-enone-O-methyloxime (ABP688) derivatives and the discovery of a high affinity analogue as a potential candidate for imaging metabotropic glutamate recepors subtype 5 (mGluR5) with positron emission tomography (PET).
Baumann CA; Mu L; Johannsen S; Honer M; Schubiger PA; Ametamey SM
J Med Chem; 2010 May; 53(10):4009-17. PubMed ID: 20411954
[TBL] [Abstract][Full Text] [Related]
8. Effect of (Z)-isomer content on [
Smart K; Cox SML; Kostikov A; Shalai A; Scala SG; Tippler M; Jaworska N; Boivin M; Séguin JR; Benkelfat C; Leyton M
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1175-1178. PubMed ID: 30607444
[TBL] [Abstract][Full Text] [Related]
9. Preclinical evaluation and test-retest studies of [(18)F]PSS232, a novel radioligand for targeting metabotropic glutamate receptor 5 (mGlu5).
Sephton SM; Herde AM; Mu L; Keller C; Rüdisühli S; Auberson Y; Schibli R; Krämer SD; Ametamey SM
Eur J Nucl Med Mol Imaging; 2015 Jan; 42(1):128-37. PubMed ID: 25139517
[TBL] [Abstract][Full Text] [Related]
10. Automated radiosynthesis of [
Milicevic Sephton S; Miklovicz T; Russell JJ; Doke A; Li L; Boros I; Aigbirhio FI
J Labelled Comp Radiopharm; 2020 Mar; 63(3):151-158. PubMed ID: 32027052
[TBL] [Abstract][Full Text] [Related]
11. Synthesis, radiolabeling, in vitro and in vivo evaluation of [18F]-FPECMO as a positron emission tomography radioligand for imaging the metabotropic glutamate receptor subtype 5.
Lucatelli C; Honer M; Salazar JF; Ross TL; Schubiger PA; Ametamey SM
Nucl Med Biol; 2009 Aug; 36(6):613-22. PubMed ID: 19647167
[TBL] [Abstract][Full Text] [Related]
12. In vivo variation in metabotropic glutamate receptor subtype 5 binding using positron emission tomography and [11C]ABP688.
DeLorenzo C; Kumar JS; Mann JJ; Parsey RV
J Cereb Blood Flow Metab; 2011 Nov; 31(11):2169-80. PubMed ID: 21792244
[TBL] [Abstract][Full Text] [Related]
13. Test-retest stability of cerebral mGluR₅ quantification using [¹¹C]ABP688 and positron emission tomography in rats.
Elmenhorst D; Aliaga A; Bauer A; Rosa-Neto P
Synapse; 2012 Jun; 66(6):552-60. PubMed ID: 22290765
[TBL] [Abstract][Full Text] [Related]
14. Sex differences in [
Smart K; Cox SML; Scala SG; Tippler M; Jaworska N; Boivin M; Séguin JR; Benkelfat C; Leyton M
Eur J Nucl Med Mol Imaging; 2019 May; 46(5):1179-1183. PubMed ID: 30627817
[TBL] [Abstract][Full Text] [Related]
15. Quantitative evaluation of 11C-ABP688 as PET ligand for the measurement of the metabotropic glutamate receptor subtype 5 using autoradiographic studies and a beta-scintillator.
Wyss MT; Ametamey SM; Treyer V; Bettio A; Blagoev M; Kessler LJ; Burger C; Weber B; Schmidt M; Gasparini F; Buck A
Neuroimage; 2007 Apr; 35(3):1086-92. PubMed ID: 17320417
[TBL] [Abstract][Full Text] [Related]
16. A PET Tracer for Brain α2C Adrenoceptors, (11)C-ORM-13070: Radiosynthesis and Preclinical Evaluation in Rats and Knockout Mice.
Arponen E; Helin S; Marjamäki P; Grönroos T; Holm P; Löyttyniemi E; Någren K; Scheinin M; Haaparanta-Solin M; Sallinen J; Solin O
J Nucl Med; 2014 Jul; 55(7):1171-7. PubMed ID: 24799619
[TBL] [Abstract][Full Text] [Related]
17. Radiosynthesis of a Bruton's tyrosine kinase inhibitor, [
Dahl K; Turner T; Vasdev N
J Labelled Comp Radiopharm; 2020 Sep; 63(11):482-487. PubMed ID: 32726870
[TBL] [Abstract][Full Text] [Related]
18. A first-in-man PET study of [
Warnock G; Sommerauer M; Mu L; Pla Gonzalez G; Geistlich S; Treyer V; Schibli R; Buck A; Krämer SD; Ametamey SM
Eur J Nucl Med Mol Imaging; 2018 Jun; 45(6):1041-1051. PubMed ID: 29177707
[TBL] [Abstract][Full Text] [Related]
19. Automated radiosynthesis of [
Kawamura K; Hashimoto H; Ohkubo T; Hanyu M; Ogawa M; Nengaki N; Arashi D; Kurihara Y; Fujishiro T; Togashi T; Sakai T; Muto M; Takei M; Ishii H; Saijo T; Matsumura T; Obokata N; Zhang MR
J Labelled Comp Radiopharm; 2022 May; 65(5):140-146. PubMed ID: 35122288
[TBL] [Abstract][Full Text] [Related]
20. Human PET studies of metabotropic glutamate receptor subtype 5 with 11C-ABP688.
Ametamey SM; Treyer V; Streffer J; Wyss MT; Schmidt M; Blagoev M; Hintermann S; Auberson Y; Gasparini F; Fischer UC; Buck A
J Nucl Med; 2007 Feb; 48(2):247-52. PubMed ID: 17268022
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
